Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Weight per mL Testing – V 2.0

Posted on By

Elixir Department: SOP for Weight per mL Testing – V 2.0

Standard Operating Procedure for Weight per mL Testing During Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/205/2025
Supersedes SOP/ELX/205/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To lay down the procedure for performing and documenting weight per mL testing (also referred to as density or specific gravity testing) of elixir formulations during manufacturing, ensuring consistency in batch quality and regulatory compliance.

2. Scope

This SOP applies to all in-process and finished product weight per mL testing conducted on elixir batches in the Elixir Department. The procedure covers testing at key stages including post-blending and post-final volume adjustment.

3. Responsibilities

  • Production Operator:
    • Assist in providing the sample to QC and record batch-related data in the BMR.
  • QC Analyst:
    • Perform weight per mL testing as per method and document the results.
    • Ensure balances are calibrated and environmental conditions are suitable.
  • QA Officer:
    • Verify results and ensure compliance with specified limits.
See also  Elixir Department: SOP for Transfer of Materials to Quarantine Area Post Dispensing - V 2.0

4. Accountability

The QC Head is accountable for method accuracy and reporting. The Production Head ensures sample integrity. The QA Head

is accountable for batch approval based on accurate testing data.

5. Procedure

5.1 Sample Collection

  1. Collect approximately 50 mL of sample from the bulk elixir tank after final mixing and before filtration/filling.
  2. Use a clean, dry, and pre-labeled glass or PET container with tamper-proof seal.
  3. Label the sample with batch number, date, sampling point, and time.

5.2 Weight per mL Testing

  1. Use a calibrated pycnometer, density bottle, or a 10 mL calibrated volumetric pipette and analytical balance.
  2. Calibrate the balance before use as per SOP/QC/BAL/001.
  3. Procedure:
    • Weigh the empty, clean, and dry container (W1).
    • Fill exactly 1.0 mL of elixir using a calibrated pipette.
    • Weigh the filled container (W2).
    • Calculate weight per mL = W2 – W1 (in g/mL).
  4. Repeat the test in triplicate and calculate the average value.
See also  Elixir Department: SOP for Receiving of Raw Materials for Elixirs - V 2.0

5.3 Acceptance Criteria

  1. As per product specification listed in BMR or COA.
  2. Typical range: ±1.5% of theoretical density.
  3. In case of out-of-specification results, notify QA immediately and hold the batch for investigation.

5.4 Precautions

  1. Ensure no air bubbles during pipetting.
  2. Do not expose sample to light or heat before testing.
  3. Clean and dry equipment thoroughly between replicates.

5.5 Documentation

  1. Record all values in the Weight per mL Testing Logbook (Annexure-1).
  2. Attach balance calibration certificate and pipette calibration record.
  3. Include results and calculations in the BMR for QA review.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • BMR: Batch Manufacturing Record
  • COA: Certificate of Analysis
See also  Elixir Department: SOP for Shelf-Life Testing Protocol - V 2.0

7. Documents

  1. Weight per mL Testing Logbook (Annexure-1)
  2. Balance Calibration Record
  3. Batch Manufacturing Record (BMR)

8. References

  • IP/USP/BP General Chapter – Specific Gravity / Density
  • 21 CFR Part 211.160 – Laboratory Controls
  • WHO TRS 986 – Good Manufacturing Practices

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Weight per mL Testing Logbook

Date Batch No. W1 (g) W2 (g) Weight/mL (g/mL) Average Result Tested By QA Verified
11/04/2025 ELX-0425-024 12.500 13.780 1.280 1.279 Pass Rajesh Kumar Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial Release New SOP QA Head
11/04/2025 2.0 Clarified procedure for using volumetric pipette method Method Enhancement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: SOP for Assay Development for Granules for Suspension – V 2.0
Next Post: When Approved SOPs Remain Ineffective: GMP Risks from Missing Effective Dates

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version